Latest Health News

TrivarX has launched a pivotal mental health clinical trial in partnership with the US Department of Veterans Affairs, leveraging its innovative ECG-based technology to screen for major depressive episodes. The company also secured $2.25 million in funding, positioning it for regulatory milestones ahead.

Piche Resources Limited reported a solid cash position for Q1 2025, underpinned by a significant AUD 9.14 million equity raise and a closing cash balance of AUD 5.8 million. Despite ongoing operating outflows, the company’s funding runway remains robust, offering a comfortable buffer for its exploration activities.

Geopacific Resources has completed a $40 million entitlement offer to fund a major drilling campaign and an updated Definitive Feasibility Study for its 1.67 million ounce Woodlark Gold Project, positioning the company for significant resource growth and project advancement.

Latrobe Magnesium Limited is poised to commence operations at its Demonstration Plant by late May 2025, backed by a $6.3 million funding boost and strategic advances in its international and commercial projects.

North Stawell Minerals Ltd reported a significant reduction in cash reserves for the quarter ending March 2025, highlighting a potential capital raising as exploration activities near completion.

Mayur Resources has completed a significant $100.1 million capital raise and secured $115 million in debt to fully fund its Central Lime Project in Papua New Guinea, while progressing construction and community agreements. The company is also rebranding to Pacific Lime and Cement Limited to reflect its new strategic focus.

dorsaVi’s Q3 FY25 report reveals growing adoption of its AI-powered video movement analysis in the US, a new elite athlete research partnership, and the launch of a pioneering 3D ACL injury prevention test.

Equity Story Group Ltd reported a robust 56% revenue increase in the March 2025 quarter, driven by strong fund performance and membership growth, alongside a strategic investment and plans to acquire Baker Young Limited.

MedAdvisor Limited reports a steep decline in 3Q FY25 revenue, driven by US market challenges, while accelerating cost-cutting and reaffirming full-year guidance.

Arizona Lithium advances its Prairie Project with a pioneering commercial development plan for lithium brine extraction, regulatory approvals, and a $1.3 million capital raise to fund initial production.

Little Green Pharma reported a robust 40% revenue increase for FY25, driven by strong European sales and the strategic acquisition of Health House. The company also advanced clinical research and secured new therapy funding, positioning itself for continued growth.

Omni Bridgeway reports robust investment performance for FY25, highlighted by record proceeds and a landmark Fund 9 transaction that strengthens its balance sheet and strategic position.